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Background: A full evaluation of health conditions is necessary for the effective implementation of public health
interventions. However, terms to address the intermediate state between health and disease are lacking, leading
the public to overlook this state and thus increasing the risks of developing disease.
Methods: A cross-sectional health survey of 1,473 randomly recruited Chinese Han adults of both sexes living in
the central region of China. The criteria for diagnosis of subhealth was defined as the presence of ≥ 1 of the
following abnormalities: body mass index ≥ 25 kg/m2 or waist circumference ≥ 102 cm in men and 88 cm in
women; systolic pressure 120–139 mmHg and/or diastolic pressure 80–89 mmHg; serum triglyceride level ≥ 150
mg/dL and/or total cholesterol level ≥ 200 mg/dL and/or high-density lipoprotein cholesterol level < 40 mg/dL in
men and 50 mg/dL in women; serum glucose level 110–125 mg/dL; estimated glomerular filtration rate 60–89 ml/
min/1.73 m2; levels of liver enzymes in liver function tests between 41–59 U/L, or with fatty liver disease but < 33%
of affected hepatocytes; levels of oxidative stress biomarkers beyond the reference range of 95%; or problems with
both sleep quality and psychological state.
Results: The prevalences of subhealth and disease in the central region of China were 36.6% and 43.1%,
respectively. The prevalence of disease increased from 26.3% in participants aged 20–39 years, to 47.6% and 78.9%
for participants aged 40–59 years and those aged 60 years or older, respectively. Compared with participants aged
20–39, the prevalences of health and subhealth in participants aged 60 years or older decreased by 86.7% and
60.3%, respectively. The prevalence of subhealth was increased in association with increases in lifestyle risk scores,
while the prevalences of both health and disease were reduced.
Conclusion: The prevalences of subhealth and disease are high in central China. Subhealth is associated with high
lifestyle risk scores. Both the health care sector and the public should pay more attention to subhealth. Lifestyle
modifications and/or psychological interventions are needed to ameliorate these conditions.
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A full evaluation of health conditions is necessary for the
effective implementation of public health interventions.
However, terms to address the intermediate state between
health and disease are lacking, leading the public to over-
look this state, and thus increasing the risks of developing
disease. We therefore coined the term ‘subhealth’ by
added the prefix ‘sub’ meaning ‘beneath’ to health, to rep-
resent pre-disease condition. This was defined as a state
characterized by some disturbances in psychological be-
haviors or physical characteristics, or in some indices of
medical examination, with no typical pathologic features.
Although metabolic syndrome, which is a combination
of disturbed fasting glucose, fat accumulation and distri-
bution, blood pressure, and blood lipids, meets some char-
acteristics of subhealth, it mainly represents a collection of
risk factors for developing type 2 diabetes mellitus and
cardiovascular diseases [1-5]. Moreover, even regardless of
various diagnostic criteria for metabolic syndrome have
been proposed by different organizations [2,3,6-10], the
metabolic syndrome as an entity might only be of con-
ceptual value, and cardiovascular risk associated with the
syndrome seems to be no greater than sum of its compo-
nents [11,12]. A recent longitudinal cohort study in non-
diabetic individuals has also illustrated that fasting plasma
glucose levels are as good as or potentially better than
metabolic syndrome for predicting diabetes [13]. Further-
more, the inclusive and exclusive criteria for metabolic
syndrome are imperfect, with little or no accounting for
psychological behaviors and physical characteristics, and
with the inclusion of some diseases, such as hypertension
and diabetes [8,12,14]. Thus the importance of metabolic
syndrome for estimating public health and general health
care may be limited.
Considering that allostasis, or homeostasis, is the basis
of all physiological and psychological activities [15,16],
allostatic load or stress, should be a common process be-
hind all-cause diseases, and a potential index of overall
health conditions. Allostatic load or stress occurs when
allostasis is targeted by stressful stimuli, and the normal
psychological and/or physiological states, and even health
conditions, are threatened [15,17]. Metabolic syndrome
may represent stress largely related to the stressful stimuli
of the “coach potato” lifestyle (high calorie intake and
physical inactivity). However, stresses induced by other
stimuli would also be expected to influence health.
Because stress represents disturbed allostasis, a subse-
quent energy-consuming recovery process is likely to be
recruited by several biological systems, leading to en-
hanced production of reactive oxygen species and conse-
quent oxidative stress. This suggests that oxidative stress,
a potential index of general stress, might be regarded as
one component of subhealth. Accumulating data indicate
an essential role for oxidative stress in the mechanismsunderlying the development and progression of metabolic
syndrome [18,19] and even aging and age-related diseases
[20,21]. To the best of our knowledge, no reports have in-
cluded oxidative stress in assessments of the general pub-
lic health state.
By combining general stress, psychological behaviors,
physical characteristics and some indices of medical exam-
inations, we sought to establish criteria for the diagnosis
of subhealth, and to estimate the potential prevalence of
subhealth in the central region of China. Subhealth was
evaluated in volunteers by measuring oxidative stress, in-
dicated by plasma levels of thiobarbituric acid-reactive




The chemicals 1,1,3,3-tetramethoxypropane and thiobar-
bituric acid were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Other chemicals (analytical grade) were
from Sangon Biotech Co. Ltd. (Shanghai, China). Water
was produced using a Milli-Q Plus purification system
(Millipore, Bedford, MA).
Participants and questionnaire
The study was approved by the Ethics Committee/Institu-
tional Review Board of Hunan Normal University. All
study volunteers signed informed consent forms before
their inclusion in the project. From September 2009 to
August 2011, a consecutive unselected recruitment was
applied to recruit the subjects from those attending our
institution. The total study subjects consisted of 1615
Chinese Han adults of both genders living in the urban
area of Changsha City in the Central Region of China.
After excluded the subjects missing baseline data, 1473
adults were included in analysis. The basic characteristics
of the participants are shown in Table 1.
The questionnaire recorded information on demograph-
ics (age and gender), lifestyle habits (sleep, diet, smoking
history, drinking history and physical activity), detailed
medical history, and psychological state. The question-
naire included five possible answers for sleep quality: well,
insomnia, dreaminess, restless sleep, and other problems.
There were six possible options for psychological state:
well, fugue, anxiety, nervousness, agitation, and depres-
sion. Subjects whose answers contained at least one ‘well’
for sleep quality or psychological state were not classified
as suffering from mental subhealth.
Lifestyle risk score
As shown in Table 2, the lifestyle risk score (LRS) was cal-
culated by summing the scores from five lifestyle factors:
diet intake, sleep quality, tobacco consumption, alcohol
intake, and physical activity level. Each was scored on the
Table 1 Basic characteristics of the 1473 Chinese adult participants§
Factors All (N =1473) Health (N = 299) Subhealth (N = 539) Disease (N = 635)
Age, mean (SD), years 44.27 (14.52) 36.38 (10.92) 40.98 (12.11) ** 50.67 (15.14) **††
Gender, male, No% 993 (67.41) 164 (55.07) 370 (68.83) 459 (72.53)
Blood pressure, mean (SD) ,mmHg
Systolic 123.14(15.92) 108.64 (8.42) 119.45 (11.22) ** 130.79 (16.92) **††
Diastolic 75.05 (11.46) 65.77 (6.30) 72.75 (8.67) ** 79.93 (12.43) **††
Blood lipids, mean (SD), mmol/L
Total cholesterol 4.40 (0.84) 3.94 (0.77) 4.39 (0.84) ** 4.54 (0.84) **†
Triglyceride 1.64 (1.27) 0.93 (0.60) 1.53 (1.00) ** 1.96 (1.53) **††
FBG, mean (SD), mmol/L 5.03 (1.26) 4.66 (0.47) 4.77 (0.53) ** 5.36 (1.70) **††
BMI, mean (SD), kg/m2 23.71 (3.22) 21.06 (2.07) 23.40 (2.82) ** 24.80 (3.31) **††
Creatinine, mean (SD), μmol/L 84.72 (16.54) 72.12 (12.66) 84.63 (15.30) ** 88.15 (16.86) **††
eGFR, mean (SD), ml/min per 1.73m2 93.68 (17.66) 108.35 (8.96) 93.82 (15.29) ** 86.69 (18.37) **††
Liver function, mean (SD) U/L
ALT 27.99 (23.69) 21.22 (17.78) 26.21 (19.34) ** 31.88 (27.93) **††
AST 22.95 (10.00) 19.91 (7.00) 22.20 (9.10) ** 24.64 (11.24) **††
TBARS, mean (SD), μmol/L 3.72 (1.21) 3.31 (0.80) 3.71 (1.14) ** 3.92 (1.36) **†
Sleep quality, well, No (%) 1001 (67.96) 215 (71.90) 341 (63.30) 445 (70.10)
Healthy diet intake, No (%) 791 (53. 70) 149 (50.00) 281 (52.10) 360 (56.71)
Current tobacco consumption, No (%) 584 (39.65) 91 (30.04) 235 (43.68) 258 (40.68)
Current alcohol intake, No (%) 804 (54.58) 141 (47.36) 303 (56.02) 360 (56.70)
Physical activity level, >1h/w, No (%) 427 (28.99) 64 (21.18) 143 (26.50) 220 (34.64)
LRS, mean (SD) 2.28 (1.23) 2.10 (1.21) 2.44 (1.26) ** 2.24 (1.22) ††
§The 1473 Chinese Han adult participants were recruited from the urban area of Changsha City in the Central Region of China from September 2009 to August
2011, aged 20–91 and both genders.
**P<0.01 compared to healthy subjects; †P<0.05 compared to subhealthy subjects; ††P<0.01 compared to subhealthy subjects.
Abbreviations: FBG, fasting blood glucose; BMI, body mass index; eGFR, estimated glomerular filtration rate; ALT, alanine aminotransferase; AST, aspartate
aminotransferase; TBARS, thiobarbituric acid-reactive substances; LRS, lifestyle risk scores.
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subject was thus assigned a score of 0–5, where a higher
score implied an unhealthier lifestyle.
Blood sampling
After overnight fasting (12 hours), blood samples (5 mL)
from the median cubital vein on the inside of the elbow
were collected into vacutainer tubes containing ethyleneTable 2 Lifestyle risk scores§
Lifestyles Assigned scores
1 0
Diet intake unhealthy healthy
Sleep quality not too well well
Tobacco consumption yes no
Alcohol intake yes no
Physical activity level ≤1h/w >1h/w
§The scores were applied to 1473 Chinese Han adult recruited from the urban
area of Changsha City in the Central Region of China from September 2009 to
August 2011, aged 20–91 and both genders.diamine tetra-acetic acid, according to standard blood
collection procedures [22], and stored at 0–4°C. All ana-
lyses were carried out within 8 h of sampling.
Physical examination
Stature, body weight and body mass index (BMI) were
detected using an ultrasonic body scale (SK-CK; Sonka
Electronic Technologies Co. Ltd., Shenzhen, China). The
BMI cut-off point for overweight was 25 kg/m2, as advo-
cated by the World Health Organization (WHO) [23].
After resting for 30 min, each participant’s blood pres-
sure was measured three times in the sitting position, with
the right arm relaxed and well supported by a table, at an
angle of 45° from the trunk, using an automatic electronic
sphygmomanometer (Ken2-BPMSP-1; Pengcheng Health-
care Products Co. Ltd., Shenzhen, China). According to
the suggestion of the American Heart Association [24],
subjects whose mean systolic/diastolic blood pressures
were ≥ 140 mmHg/90 mmHg, or who were receiving anti-
hypertensive medication were classified as hypertensive,
those with blood pressure of 120–139 mmHg/80–89
Table 3 Criteria for diagnosis of subhealth and disease§
Factors Subhealth Disease
Blood pressure (mmHg)
Systolic pressure 120-139 ≥ 140






Total cholesterol ≥ 5.17
BMI (kg/m2) ≥25






















Renal function (ml/min per 1.73m2)
eGFR 60-89 < 60
Mental state
Sleep quality Both have some
problems
Psychological state
§The criteria were applied to 1473 Chinese Han adult recruited from the urban
area of Changsha City in the Central Region of China from September 2009 to
August 2011, aged 20–91 and both genders.
Abbreviations: BMI, body mass index; TBARS, thiobarbituric acid-reactive
substances; ALT, alanine aminotransferase; AST: aspartate aminotransferase;
FLD, fatty liver disease; eGFR, estimated glomerular filtration rate.
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blood pressure were defined as prehypertensives, and those
with blood pressure of 90–119 mmHg/60–79 mmHg were
classified as normotensive.
Blood lipids (serum total cholesterol and triglycerides),
fasting plasma glucose, renal function (serum creatinine)
and liver function (aspartate transaminase [AST], and
alanine transaminase [ALT]) were measured using a chro-
matographic enzymatic method with a Mindray BS-40
automatic analyzer (Mindray Co. Ltd., Shenzhen, China).
Serum hepatitis B viral antigens and antibodies were
detected using a microplate reader (MR-96; Mindray Co.Ltd.). The diagnosis of fatty liver disease (FLD) was based
on ultrasound examination using a Mindray DP-9900 Plus
Digital B/W Ultrasound System (Mindray Co. Ltd.).
Serum total cholesterol and serum triglycerides were
categorized as normal, borderline high, or high, based on
the Third Report of the National Cholesterol Education
Program Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III) final report [10]. Fasting blood glu-
cose was classified as normal (< 6.0 mM), pre-diabetic
(6.1–6.9 mM), or diabetic (> 7.0 mM), on the basis of the
WHO criteria [2,25].
The estimated glomerular filtration rate (eGFR) was cal-
culated from serum creatinine using the Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI) formula
[26]. Based on eGFR, renal function was categorized
according to the related classifications [27,28]: health
(eGFR ≥ 90 ml/min/1.73 m2 and no proteinuria), sub-
health (60 ≤ eGFR < 90 ml/min/1.73 m2 and no protein-
uria) and disease (eGFR < 60 ml/min/1.73 m2 or with
proteinuria).
Hepatic health (all diagnostic indices of liver function,
FLD and hepatitis B were normal), subhealth (mild FLD
or slightly elevated levels of ALT or AST) and disease
(hepatitis, severe FLD, high levels of ALT or AST, or both
mild FLD and high levels of ALT or AST) were grouped
on the basis of liver function tests, FLD and hepatitis B,
and related reference ranges or guidelines [29-31].
TBARS assay
A modified thiobarbituric acid method [32] was used to
determine the level of oxidative stress in plasma. Level of
oxidative stress was expressed as TBARS determined
using an LS-50B spectrofluorometer (Perkin-Elmer Corp.,
Norwalk, USA).
Criteria for diagnosis of subhealth
According to the definition of subhealth, subjects with
mental subhealth, overweight, prehypertension, pre-dia-
betes, serum blood lipids (triglycerides or total choles-
terol) above the borderline high level, renal subhealth,
hepatic subhealth or TBARS ≥ 5.09 μmol/L (based on the
reference range of 95%) were categorized as subhealthy. In
detail, the criteria for diagnosis of subhealth was defined
as the presence of ≥ 1 of the following abnormalities, in
the absence of disease characteristics: body mass index ≥
25 kg/m2 or waist circumference ≥ 102 cm in men and 88
cm in women; systolic pressure 120–139 mmHg and/or
diastolic pressure 80–89 mmHg; serum triglyceride level ≥
150 mg/dL (1.69 mmol/L) and/or total cholesterol level ≥
200 mg/dL (5.17 mmol/L) and/or high-density lipoprotein
cholesterol level < 40 mg/dL (1.04 mmol/L) in men and
50 mg/dL (1.29 mmol/L) in women; serum glucose level
110–125 mg/dL (6.1–6.9 mmol/L); estimated glomerular
Table 4 The prevalence of health, subhealth, disease by
different factors§
Factors Health Subhealth Disease
Blood pressure, No (%) 828 (56.21) 455(30.89) 190 (12.90)
Fasting blood glucose, No (%) 1381 (93.75) 45 (3.05) 47 (3.19)
Blood lipids
Total cholesterol, No (%) 1302 (88.39) 171(11.61) -
Triglyceride, No (%) 1296 (87.98) 177(12.02) -
BMI, No (%) 1107 (75.15) 366(24.85) -
TBARS, No (%) 1399 (94.98) 74(5.02) -
Liver function, No (%) 1101 (74.75) 217 (14.73) 155 (10.52)
eGFR, No (%) 951 (64.56) 406 (27.56) 116 (7.88)
Mental state, No (%) 1288 (87.44) 185 (12.56) -
With other diseases - - 181(12.29)
§The subjects were 1473 Chinese Han adult recruited from the urban area of
Changsha City in the Central Region of China from September 2009 to August
2011, aged 20–91 and both genders.
Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration
rate; TBARS, thiobarbituric acid-reactive substances.
Figure 1 Age-specific prevalence of health, subhealth and
disease among 1473 Chinese adults. The 1473 Chinese Han adult
participants were recruited from the urban area of Changsha City in
the Central Region of China from September 2009 to August 2011,
aged 20–91 and both genders. Data were presented as
percentage (SE).
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zymes in liver function tests between the upper limit of
normal and 50% above the upper limit of normal (41–59
U/L), or with fatty liver disease but < 33% of affected he-
patocytes; levels of oxidative stress biomarkers beyond the
reference range of 95%; or problems with both sleep qual-
ity and psychological state. Those self-reported or diag-
nosed with any disease, or with symptoms of hypertension
or diabetes, were defined as diseased, and those with no
sign of subhealth or disease were classified as healthy
(Table 3).
Statistics
Results were presented as means ± standard deviation
(SD). Statistical analysis of data was performed using
predictive analytics software statistics 18.0 (SPSS Inc.,
Chicago, IL). The reference range of 95% for TBARS was
calculated based on the TBARS dataset after removal of
the outliers using Grubbs’ test at α = 0.05 [33]. The
Kruskal-Wallis test was used for comparisons between
groups. A P value < 0.05 was considered statistically
significant.
Results
The prevalences of subhealth and disease in the central re-
gion of China were 36.6% and 43.1%, respectively, while
healthy participants accounted for only 20.3% of the total
population (Table 1). There were significant differences in
age and most factors of physical examination among the
healthy, subhealthy and diseased groups. Although no life-
style factor was independently and significantly associated
with health state, the LRS was significantly higher in
subhealthy participants (Table 1). Futher results fromdifferent diagnostic criteria displayed that blood pressure,
BMI and eGFR were main responsible for the high preva-
lence of subhealth (Table 4).
The age-specific prevalences of health, subhealth and
disease showed that the overall health state decreased
gradually with increasing age (Figure 1). The prevalence of
disease increased from 26.3% in participants aged 20–39
years, to 47.6% and 78.9% for participants aged 40–59
years and 60 years or older, respectively. The prevalences
of both health and subhealth showed concomitant age-
related decreases. Compared with participants aged 20–
39, the prevalences of health and subhealth in participants
aged 60 years or older decreased by 86.7% and 60.3%, re-
spectively (Figure 1). There was no obvious difference in
the prevalence of subhealth between males and females
(Figure 2).
The prevalences of health, subhealth, and disease by
LRS were further analyzed. Intriguingly, only the preva-
lence of subhealth was obviously enhanced with increas-
ing LRS, while the prevalences of both health and
disease were reduced (Figure 3).
Discussion
To our knowledge, this is the first definition for
subhealth that fills the terminology gap between health
and disease. This definition is necessary to draw people’s
attention to their lifestyles, and to allow them to recover
their physical and psychological states of health. If we re-
gard health and disease as green and red traffic lights, re-
spectively, then subhealth is the amber light. The
absence of any light will increase the risk of a health-
state traffic jam, as indicated by the results of this study.
Subhealthy participants had the highest LRS, and only
Figure 2 Age-specific prevalence of subhealth by gender
among 1473 Chinese adults. The 1473 Chinese Han adult
participants were recruited from the urban area of Changsha City in
the Central Region of China from September 2009 to August 2011,
aged 20–91 and both genders. Data were presented as
percentage (SE).
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with LRS. It is possible that, in the absence of any term
defining the subhealthy condition, people fail to see the
amber light and do not appreciate the need to make
changes to their lifestyles or other factors.
We have therefore developed systematic diagnostic cri-
teria for subhealth, based on the diagnostic criteria for
metabolic syndrome [10,12,14], supplemented by mea-
sures of oxidative stress to represent general stress, com-
bined sleep and psychological state for mental status,
CKD-EPI-based eGFR for renal function, and liver relatedFigure 3 The prevalence of health, subhealth, disease by LRS
among 1473 Chinese adults. The 1473 Chinese Han adult
participants were recruited from the urban area of Changsha City in
the Central Region of China from September 2009 to August 2011,
aged 20–91 and both genders. Data were presented as
percentage (SE).examinations for hepatic function state. These criteria,
including general stress and physical and psychological
conditions, provide information about the overall state of
health. Moreover, a diagnosis is not difficult to achieve. It
is possible to focus on an organ for organ-specific
subhealth, or add an index of general stress and an easily-
completed questionnaire and medical examination for
overall subhealth.
The difference between subhealth and disease lies not
only in the levels of the indices used, but more import-
antly in the means to recovery: generally, the cure of dis-
ease requires medication, while the threat to public health
posed by subhealth can be eliminated simply by psycho-
logical interventions and/or lifestyle modifications. Several
studies have suggested that physical activity, healthy diet
and other lifestyle modifications can favorably affect com-
ponents of subhealth [34-36]. However, subhealthy indi-
viduals are at high risk of developing disease if not treated
in time.
Unhealthy lifestyles are associated with high risks of dis-
ease and mortality, while lifestyle improvements are asso-
ciated with reductions in disease and all-cause mortality.
Numerous studies have illustrated that healthy diet, mod-
erate exercise, quitting cigarette smoking, and avoiding
heavy drinking are separately associated with lower rates
of death from all causes [37-42]. However, there are lim-
ited published studies reporting the relationship between
combined lifestyle factors and mortality or diseases. By
assigning a score of 1 for each poor lifestyle factor (un-
healthy diet, sleep problems, smoking, drinking, and < 1
hour of physical activity per week) we calculated a com-
bined LRS ranging from 0–5 for each subject. Based on
this score, we demonstrated a positive effect of LRS on the
prevalence of subhealth, and a negative effect on health
and disease. It is possible that participants with disease,
but not those defined as subhealthy, paid more attention
to their lifestyles, which might explain why the correla-
tions between mortality or disease and independent life-
style factors was not always consistent.
In this cross-sectional study, we found approximately
80% of Chinese adults were subhealthy or diseased, based
on our diagnostic criteria. This result is much higher than
the reported prevalence of metabolic syndrome (23.7%),
and even higher than the prevalence of one abnormal char-
acteristic of metabolic syndrome (71.2%) reported in the
Third National Health and Nutrition Examination Survey
[43]. However, appropriate interventions could theoretically
recover health from subhealth (with a prevalence of 36.6%).
There is therefore an urgent need for the government, es-
pecially the health care sector, to make comprehensive ef-
forts to lower the prevalence of subhealth. The cornerstone
of intervention should be to reduce the LRS to zero.
The strengths of this study include the fact that it pro-
vides the first definition and criteria for the diagnosis of
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conditions feasible, and allowing the implementation of
effective interventions. The application of LRS to in-
vestigate the combined impact of lifestyle factors on
subhealth or disease is superior to assessing the inde-
pendent impact of lifestyle factors. This cross-sectional
study revealed a high prevalence of subhealth in the cen-
tral region of China, which may serve prompt a major
health care initiative aimed at treating subhealth, which
has previously been ignored.
This study also had several limitations. Firstly, its sample
was limited to Chinese Han adults from urban areas in
the central region of China, and the applicability of the re-
sults to rural residents, and other nationalities and ethnic
groups is unknown. Secondly, although TBARS is the
most widely used biomarker of oxidative stress, other
in vivo biomarkers exist, such as isoprostanes [44]. Finally,
the method of evaluating mental conditions by a combin-
ation of sleep quality and psychological factors should not
be absolute, but modify along with nationality, race and
other characteristics of participants.
Conclusion
This study provides the first definition and criteria for the
diagnosis of subhealth, making evaluation of the full state
of health conditions feasible, and allowing the implemen-
tation of effective interventions. The prevalences of sub-
health and disease are high in central China. Subhealth is
associated with high lifestyle risk scores. Both the health
care sector and the public should pay more attention to
subhealth. Lifestyle modifications and/or psychological in-
terventions are needed to ameliorate these conditions.
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